Halozyme Therapeutics (HALO) Tax Rate (2016 - 2026)

Halozyme Therapeutics (HALO) has 11 years of Tax Rate data on file, last reported at 16.79% in Q1 2026.

• On a quarterly basis, Tax Rate fell 110.0% year-over-year to 16.79% in Q1 2026; TTM through Mar 2026 was 30.69%, a 1093.0% increase from a year earlier, with the FY2025 full-year figure at 32.13%, up 1184.0% from the prior year.
• Tax Rate for Q1 2026 stood at 16.79%, up from 40.4% in the prior quarter.
• Over the last five years, Tax Rate for HALO reached as high as 24.41% in Q2 2022 and fell as low as 40.4% in Q4 2025.
• Historically, Tax Rate has averaged 16.01% across 5 years, with a median of 19.41% in 2025.
• Across the five-year window, Tax Rate soared 20865 bps in 2022 and plunged 6352 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 18.49% in 2022, then decreased by 16 bps to 15.6% in 2023, then soared by 48 bps to 23.12% in 2024, then tumbled by 275 bps to 40.4% in 2025, then surged by 142 bps to 16.79% in 2026.
• Per Business Quant data, the three most recent Tax Rate figures were 16.79% in Q1 2026, 40.4% in Q4 2025, and 19.96% in Q3 2025.